TY - JOUR
T1 - Eight years experience from a skeletal dysplasia referral center in a tertiary hospital in Southern India
T2 - A model for the diagnosis and treatment of rare diseases in a developing country
AU - Nampoothiri, Sheela
AU - Yesodharan, Dhanya
AU - Sainulabdin, Gazel
AU - Narayanan, Dhanyalakshmi
AU - Padmanabhan, Laxmi
AU - Girisha, Katta Mohan
AU - Cathey, Sara S.
AU - De Paepe, Anne
AU - Malfait, Fransiska
AU - Syx, Delfien
AU - Hennekam, Raoul C.
AU - Bonafe, Luisa
AU - Unger, Sheila
AU - Superti-Furga, Andrea
PY - 2014
Y1 - 2014
N2 - We report on a series of 514 consecutive diagnoses of skeletal dysplasia made over an 8-year period at a tertiary hospital in Kerala, India. The most common diagnostic groups were dysostosis multiplex group (n=73) followed by FGFR3 (n=49) and osteogenesis imperfecta and decreased bone density group (n=41). Molecular confirmation was obtained in 109 cases. Clinical and radiographic evaluation was obtained in close diagnostic collaboration with expert groups abroad through Internet communication for difficult cases. This has allowed for targeted biochemical and molecular studies leading to the correct identification of rare or novel conditions, which has not only helped affected families by allowing for improved genetic counseling and prenatal diagnosis but also resulted in several scientific contributions. We conclude that (1) the spectrum of genetic bone disease in Kerala, India, is similar to that of other parts of the world, but recessive entities may be more frequent because of widespread consanguinity; (2) prenatal detection of skeletal dysplasias remains relatively rare because of limited access to expert prenatal ultrasound facilities; (3) because of the low accessibility to molecular tests, precise clinical-radiographic phenotyping remains the mainstay of diagnosis and counseling and of gatekeeping to efficient laboratory testing; (4) good phenotyping allows, a significant contribution to the recognition and characterization of novel entities. We suggest that the tight collaboration between a local reference center with dedicated personnel and expert diagnostic networks may be a proficient model to bring current diagnostics to developing countries.
AB - We report on a series of 514 consecutive diagnoses of skeletal dysplasia made over an 8-year period at a tertiary hospital in Kerala, India. The most common diagnostic groups were dysostosis multiplex group (n=73) followed by FGFR3 (n=49) and osteogenesis imperfecta and decreased bone density group (n=41). Molecular confirmation was obtained in 109 cases. Clinical and radiographic evaluation was obtained in close diagnostic collaboration with expert groups abroad through Internet communication for difficult cases. This has allowed for targeted biochemical and molecular studies leading to the correct identification of rare or novel conditions, which has not only helped affected families by allowing for improved genetic counseling and prenatal diagnosis but also resulted in several scientific contributions. We conclude that (1) the spectrum of genetic bone disease in Kerala, India, is similar to that of other parts of the world, but recessive entities may be more frequent because of widespread consanguinity; (2) prenatal detection of skeletal dysplasias remains relatively rare because of limited access to expert prenatal ultrasound facilities; (3) because of the low accessibility to molecular tests, precise clinical-radiographic phenotyping remains the mainstay of diagnosis and counseling and of gatekeeping to efficient laboratory testing; (4) good phenotyping allows, a significant contribution to the recognition and characterization of novel entities. We suggest that the tight collaboration between a local reference center with dedicated personnel and expert diagnostic networks may be a proficient model to bring current diagnostics to developing countries.
UR - http://www.scopus.com/inward/record.url?scp=84905908315&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84905908315&partnerID=8YFLogxK
U2 - 10.1002/ajmg.a.36668
DO - 10.1002/ajmg.a.36668
M3 - Article
C2 - 25044831
AN - SCOPUS:84905908315
SN - 1552-4825
VL - 164
SP - 2317
EP - 2323
JO - American Journal of Medical Genetics, Part A
JF - American Journal of Medical Genetics, Part A
IS - 9
ER -